ECDC Forward look risk assessment (Update 28 October 2010): Likely scenarios and uncertainties in the 2010/2011 influenza season in Europe and beyond
Likely scenarios and uncertainties in the 2010/2011 influenza season in Europe and beyond.
Risk assessment: Seasonal influenza 2011–2012 in Europe (EU/EEA countries)
ECDC produces an annual risk assessment for the seasonal influenza epidemics in Europe. This is following both a recommendation in the report on the handling of the 2009 pandemic adopted by the World Health Assembly in May 2011 and the model developed by ECDC during that pandemic. The first EU seasonal influenza risk assessment was published in January 2011, following the start of the influenza season in late November 2010. In 2012, the season started later than in most years, with the first five countries exceeding their epidemic threshold in week 3/2012.
Rapid risk assessment: circulation of drifted influenza A(H3N2) viruses in the EU/EEA, 22 December 2014
Surveillance data gathered since 1 October 2014 indicate that in the first ten weeks of the 2014–15 influenza season, viruses in EU/EEA countries have been predominantly A(H3N2) rather than A(H1N1)pdm09 and type B viruses.
ECDC Communicable disease threats report, Week 2, 4-10 January 2015
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4-10 January 2015, and includes updates on botulism, influenza, Ebola virus, MERS, dengue, polio, chikungunya.
ECDC press release: Seasonal influenza transmission in Europe
Today ECDC publishes its risk assessment on the 2012/13 seasonal influenza epidemics in Europe. Epidemics started earlier than in the previous season and western Europe and Scandinavia were the first affected areas.
Communicable disease threats report, 16-22 April 2017, week 16
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 16-22 April 2017 and includes updates on influenza, cholera, poliomyelitis, measles, legionnaires' disease and yellow fever.
- Avian influenza virus
- Food- and Waterborne Diseases and Zoonoses Programme
- Influenza and other Respiratory Viruses Programme
- Influenza in humans, seasonal
- Legionnaires’ disease
- Public health threat
- South America
- Vaccine Preventable Diseases Programme
- Yellow fever
WHO Europe: Influenza
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.
CDC (Centres for Disease Control and Prevention): Influenza
CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.
WHO online training courses: Preparing for pandemics - fighting against influenza threats
Every few decades a new, and potentially deadly, influenza virus emerges and spreads worldwide. These events – influenza pandemics – are a threat all countries need to prepare for. The Preparing for pandemics channel brings together courses on various aspects of preparedness, including surveillance, public health measures and risk communication during a pandemic. You can learn the basic epidemiology and virology of influenza. You can learn the differences (and similarities) between zoonotic influenza, seasonal influenza and pandemic influenza. And you can get informed about how WHO, Member States, industry and other stakeholders work together in the Pandemic Influenza Preparedness (PIP) Framework.